Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development

Metabolites(2022)10.3390/metabo12040333Source: DataRank Database

Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development is a research paper published in Metabolites (2022). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.92)OA: goldTopics (33)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Brandon Ebright ORCID,Kingsley Chow ORCID,Priyal Dave ORCID,Andrew Mead ORCID,R Poblete ORCID

Live enrichment

PubMed:35448520 PMC:PMC9030008 OpenAlex:https://openalex.org/W4224221924

United States Department of Defense

Grant: 13247254

National Institutes of Health

Grant: 5R01CA213129-05

Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment

American Foundation for Pharmaceutical Education

Grant: Fellowship

NCATS NIH HHS

Grant: UL1 TR001855

National Institutes of Health

Grant: 3UL1TR001855-06A1S1

Southern California Clinical and Translational Science Institute

FWCI

3.92

Citation Percentile

1.0%

Citation Trend

2018

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2218-1989/12/4/333/pdf?version=1649325314

publisherhttps://www.mdpi.com/2218-1989/12/4/333/pdf?version=1649325314

publisherhttps://www.mdpi.com/2218-1989/12/4/333/pdf

journalhttps://doi.org/10.3390/metabo12040333

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35448520

Fields of Study

Metabolomics and Mass Spectrometry StudiesAdvanced Proteomics Techniques and ApplicationsSphingolipid Metabolism and Signaling0301 basic medicine03 medical and health sciences

Keywords

LipidomicsMetabolomicsLipidomeBiomarker discoveryComputational biologyDrug discoveryDrug developmentBiomarkerBioinformaticsDrugMedicineProteomicsChemistryPharmacologyBiologyBiochemistryMass spectrometryInflammationNeurodegenerationCardiovascular diseaseRespiratory diseaseautoimmune diseaseEicosanoidsLipid MediatorsSpecial Pro-resolving Lipid MediatorsReviewMicrobiologyQR1-502

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 3 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605757figshare

Additional file 3 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605757.v1figshare

Additional file 4 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605760figshare

Additional file 2 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605754figshare

Additional file 1 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605751figshare

Additional file 2 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605754.v1figshare

Additional file 1 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605751.v1figshare

Additional file 4 of Vascular lipidomics analysis reveales increased levels of phosphocholine and lysophosphocholine in atherosclerotic mice

10.6084/m9.figshare.22605760.v1figshare